Canada’s Drug Agency: How Global Policy Changes Are Reshaping HTA for Rare Diseases
HTAi’s Rare Disease Interest Group will celebrate 2026 Rare Disease Day with a conversation on how global policy changes are reshaping HTA processes for rare disease technologies. The webinar aims […]
